JP2017503760A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503760A5
JP2017503760A5 JP2016534901A JP2016534901A JP2017503760A5 JP 2017503760 A5 JP2017503760 A5 JP 2017503760A5 JP 2016534901 A JP2016534901 A JP 2016534901A JP 2016534901 A JP2016534901 A JP 2016534901A JP 2017503760 A5 JP2017503760 A5 JP 2017503760A5
Authority
JP
Japan
Prior art keywords
alkyl
group
cycloalkyl
atoms
membered aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016534901A
Other languages
English (en)
Japanese (ja)
Other versions
JP6441928B2 (ja
JP2017503760A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/075358 external-priority patent/WO2015078802A1/en
Publication of JP2017503760A publication Critical patent/JP2017503760A/ja
Publication of JP2017503760A5 publication Critical patent/JP2017503760A5/ja
Application granted granted Critical
Publication of JP6441928B2 publication Critical patent/JP6441928B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016534901A 2013-11-28 2014-11-24 新規インダニルオキシフェニルシクロプロパンカルボン酸 Expired - Fee Related JP6441928B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13194945.5 2013-11-28
EP13194945 2013-11-28
PCT/EP2014/075358 WO2015078802A1 (en) 2013-11-28 2014-11-24 New indanyloxyphenylcyclopropanecarboxylic acids

Publications (3)

Publication Number Publication Date
JP2017503760A JP2017503760A (ja) 2017-02-02
JP2017503760A5 true JP2017503760A5 (enExample) 2018-01-11
JP6441928B2 JP6441928B2 (ja) 2018-12-19

Family

ID=49726512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016534901A Expired - Fee Related JP6441928B2 (ja) 2013-11-28 2014-11-24 新規インダニルオキシフェニルシクロプロパンカルボン酸

Country Status (4)

Country Link
US (1) US9308194B2 (enExample)
EP (1) EP3074375B1 (enExample)
JP (1) JP6441928B2 (enExample)
WO (1) WO2015078802A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3544958B1 (en) * 2016-11-28 2021-03-24 Boehringer Ingelheim International GmbH Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
WO2018138026A1 (en) * 2017-01-26 2018-08-02 Boehringer Ingelheim International Gmbh Indanylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
JP7049353B2 (ja) * 2017-02-08 2022-04-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病の治療のためのインダニルアミノアザジヒドロベンゾフラニル酢酸、医薬組成物
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
WO2019160882A1 (en) 2018-02-13 2019-08-22 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR102591947B1 (ko) 2018-04-19 2023-10-25 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
PE20210642A1 (es) 2018-07-13 2021-03-23 Gilead Sciences Inc Inhibidores de pd-1/pd-l1
US11236085B2 (en) 2018-10-24 2022-02-01 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
JP7135931B2 (ja) 2019-02-22 2022-09-13 スズキ株式会社 車両の走行制御装置
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ，インク． Ｇｐｒ１１９アゴニスト
MX2022010548A (es) 2020-02-28 2022-09-23 Kallyope Inc Agonistas de gpr40.
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
NZ588983A (en) * 2008-06-25 2011-11-25 Daiichi Sankyo Co Ltd Carboxylic acid compound
EP2646425B1 (en) * 2010-12-01 2015-06-10 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids useful for the treatment of metabolic syndrome

Similar Documents

Publication Publication Date Title
JP2012513416A5 (enExample)
JP2014525420A5 (enExample)
JP2015511613A5 (enExample)
SI2738156T1 (en) TETRACYCLINE COMPOSITE SUBSTITUTED WITH 9-AMINOMETHYL
JP2016536363A5 (enExample)
JP2015531773A5 (enExample)
JP2010504286A5 (enExample)
JP2013507423A5 (enExample)
JP2014502988A5 (enExample)
JP2013507434A5 (enExample)
JP2013531029A5 (enExample)
RU2015149009A (ru) 19-нор нейроактивные стероиды и способы их применения
JP2011137006A5 (enExample)
JP2015523383A5 (enExample)
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
MX2022008434A (es) Herbicidas de piridazinona.
BR112012022125A2 (pt) composto, sal de dicloridrato, composição farmacêutica, uso do composto, e, método para tratar um paciente
JP2015504091A5 (enExample)
NZ739248A (en) Inhibitors of hepatitis c virus
AR060623A1 (es) Compuestos derivados de 2-azetidinona y un metodo de preparacion
TN2019000170A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
RU2012125971A (ru) Новые химические соединения производные 2,4-диамино-1,3,5-триазина для профилактики и лечения заболеваний человека и животных
MX2016016538A (es) Derivados de quinazolinona como inhibidores de fosfatidilinositol 3-cinasa.
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.
AR073769A1 (es) Inhibidores de la integrasa del vih derivados de azepina y oxazepinas condensadas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de infecciones por vih.